| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.006 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |